Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Avelumab costs peg back profit at Merck KGaA

Development of its immuno-oncology product is central to Merck's healthcare plans

- PMLiVE

Lucid expands with launch of new strategic consultancy

Its new company will be led by Duncan Ferguson

Actelion HQ Switzerland

EU nod for Actelion’s skin cancer drug Ledaga

Still need to meet CHMP post-approval requirements

- PMLiVE

Hywel Day joins Napp Pharmaceuticals

Moves from Mundipharma to take up managing director role

- PMLiVE

emotive appoints new medical director

Dr Gill Boucher joins the agency from QuintilesIMS

- PMLiVE

Lucid Group gains further momentum with launch of new Strategic Consultancy

Lucid Group has made an exciting company expansion with the launch of the new Lucid Strategic Consultancy and the appointment of Duncan Ferguson as MD.Duncan Ferguson is highly qualified for...

Lucid Group Communications Limited

Deal Watch February 2017

Actelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

- PMLiVE

Safety issues dampen enthusiasm for Akcea’s volanesorsen

But Ionis Pharmaceuticals' subsidiary presses on with filing plans

Marketing strategy in complex environments

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what...

Blue Latitude Health

- PMLiVE

NICE set to back Parsabiv for kidney disease complication

Draft guidance recommends Amgen treatment for secondary hyperparathyroidism

UK flag

ABPI delivers wish-list to Hammond ahead of spring budget

Pharma industry has three key requests

- PMLiVE

Caldan Therapeutics appoints CEO

Dr Mark Payton joins the Universities of Glasgow and Southern Denmark spin-out

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links